CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
5.17
-0.23 (-4.26%)
Jan 29, 2026, 4:00 PM EST - Market closed

CervoMed Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21
481943--
Market Cap Growth
184.11%-55.39%---
Enterprise Value
21-2733--
Last Close Price
5.172.347.63--
PS Ratio
7.471.986.06--
PB Ratio
1.840.495.87--
P/TBV Ratio
1.840.495.87--
EV/Sales Ratio
3.33-4.60--
Debt / Equity Ratio
----1.38-2.74
Asset Turnover
0.160.371.01--
Quick Ratio
6.2310.613.360.311.48
Current Ratio
6.6611.113.840.321.50
Return on Equity (ROE)
-71.42%-69.95%---
Return on Assets (ROA)
-42.78%-42.95%-69.12%-39.59%-
Return on Capital Employed (ROCE)
-104.60%-46.50%-105.90%38.60%-223.00%
Earnings Yield
-53.48%-84.35%-5.02%--
Buyback Yield / Dilution
-19.30%-203.34%-413.65%88.49%-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q